In their report on age effects on risk of antidepressant treatment–associated mania, Martin et al1 found that children, adolescents, and young adults treated for depressive or anxiety disorders showed an increased risk of new-onset mania at ages 15 to 25 years. Rates of “conversion” to bipolar disorder (new mania) were lowest in children aged 5 to 9 years and similarly intermediate in those aged 10 to 14 years and 25 to 29 years. They also found a nearly 2-fold greater overall risk of mania with tricyclic antidepressants (TCAs) (hazard ratio vs no antidepressant exposure, 3.9) than with serotonin reuptake inhibitors (SRIs) (hazard ratio, 2.1).
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Risk (percentage of patients with depressive or anxiety disorders) of developing mania vs age during treatment with tricyclic antidepressants (TCAs), serotonin reuptake inhibitors (SRIs), any antidepressant (ADD), or no ADD. Data are adapted from Martin et al,1 with standard errors.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Pediatrics editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 15
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.